Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Charles River cuts forecasts as profits slump

August 11, 2009 Research and Development Charles River, preclinical

Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …
News

Sanofi submits FDA application for swine flu vaccine

August 10, 2009 Research and Development, Sales and Marketing Sanofi-Aventis, h1n1

Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …
News

Doubts about funding for ‘Innovation Pass’

August 10, 2009 Research and Development, Sales and Marketing ABPI, NHS, NICE

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
News

TNF blockers must carry children’s cancer warning

August 7, 2009 Research and Development, Sales and Marketing FDA, RA, TNF

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …
News

Vernalis and GSK sign risk-sharing deal

August 7, 2009 Research and Development, Sales and Marketing Deals, GSK, Vernalis

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
News

Pfizer agrees price cut in Clinton deal

August 7, 2009 Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …
News

Quintiles opens Ghana office

August 7, 2009 Research and Development Africa, Quintiles

Quintiles has opened a new office in Accra, Ghana, which it says will increase capacity to manage clinical studies for …
News
GSKfluvaccine

Racing to save lives and fighting the PR battle

August 6, 2009 Medical Communications, Research and Development Vaccine, clinical trials, public relations

Vaccine companies are working round the clock to develop and manufacture a vaccine for the H1N1 pandemic flu, and are …
Feature

Vasella targeted by animal rights activists

August 6, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …
News

Afinitor approved in EU

August 6, 2009 Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …
News

US approval for Onglyza

August 6, 2009 Research and Development, Sales and Marketing AZ, BMA, diabetes

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …
News

Kennedy and Drayson: parallel plans to boost UK’s innovation agenda

August 5, 2009 Research and Development NICE, healthcare

1: The Office of Life Science’s ‘Blueprint’The first to be launched was the ‘Blueprint’ – a new strategic vision aiming …
Feature

Joint US-European clinical inspections launched

August 5, 2009 Research and Development Europe, US

News

Boehringer’s lung cancer candidate enters phase III

August 5, 2009 Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …
News

ICR conference moves to London

August 4, 2009 Business Services, Research and Development Conference, ICR

The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026